Ethan J. Halpern, MD, presented “Contrast-Enhanced Ultrasound of the Prostate” during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019 in Boston, Massachusetts.
How to cite: Halpern, Ethan J. “Contrast-Enhanced Ultrasound of the Prostate” October 3, 2019. Accessed Nov 2024. https://dev.grandroundsinurology.com/contrast-enhanced-ultrasound-of-the-prostate/
Contrast-Enhanced Ultrasound of the Prostate – Summary:
Ethan J. Halpern, MD, Professor and Vice-Chair for Research in the Department of Radiology at Jefferson University Hospital, reviews the history and limitations of using standard grayscale and doppler TRUS imaging to identify cancers within the prostate. He further discusses contrast-enhanced ultrasound of the prostate, and how, when combined with subharmonic flash replenishment imaging, it represents a major step forward in identifying malignant vascular patterns within the prostate.
About The 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer:
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a multi-day, multi-disciplinary forum designated to inform health care stakeholders about topics including in-vitro fluid- and tissue-based molecular diagnostics, novel observation strategies such as active surveillance, and novel therapeutic interventions. Along with this forum’s efforts to form a consensus on the future of prostate diagnostics and precision care, it aims to create an educational and research strategy for its realization. Dr. Halpern presented this lecture during the 4th iteration of this summit in 2019.
ABOUT THE AUTHOR
Ethan J. Halpern, MD, is Professor and Vice-Chair for Research in the Department of Radiology at Jefferson University Hospital in Philadelphia. He also serves as Co-Director of Jefferson University Hospital’s Prostate Diagnostic Center—a collaboration among the departments of urology, radiology and pathology. In this role, Dr. Halpern actively explores the application of contrast-enhanced ultrasound (CEUS) to the diagnosis of prostate cancer (PCa). Several clinical trials at Jefferson have demonstrated improved detection of PCa based upon CEUS targeted biopsy. Recent studies have employed newer ultrasound techniques, including flash replenishment and subharmonic imaging, to improve the detection of neovascularity associated with PCa. A recent study has demonstrated the utility of CEUS to detect significant PCa that was missed by multi-parametric MRI.
